Firebrick Pharma launches first international product
Firebrick Pharma (ASX:FRE) has launched its first international product, Nasodine throat spray, in Singapore.
Firebrick Pharma (ASX:FRE) has launched its first international product, Nasodine throat spray, in Singapore.
Metallium (ASX:MTM) has completed a $75 million strategic capital raising, led by US-based institutional investors.
European Lithium (ASX:EUR) has sold 5 million ordinary shares in Critical Metals (NASDAQ:CRML), generating net proceeds of approximately $124 million.
Andrew Forrest's private mining vehicle, Wyloo Metals, has significantly increased its holding in ASX-listed Greatland Resources (ASX:GGP).
Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.
Sovereign Metals (ASX:SVM) announced a major strategic development at its Kasiya Rutile-Graphite Project in Malawi.
Algorae Pharmaceuticals (ASX:1AI) has secured a $3 million receivables-based working capital facility with ScotPac Business Finance.
EcoGraf (ASX:EGR) has announced results from its first exploration campaign at the Hazina prospect, part of its Southern Frontier Gold Project in Tanzania.
Servcorp (ASX:SRV) has upgraded its 2026 financial year guidance, citing continued operational momentum, improved revenue efficiency and strong cash generation across its global portfolio.
Clinical-stage biotech company Noxopharm (ASX:NOX) has completed the HERACLES clinical trial.
Everest Metals (ASX:EMC), in partnership with Edith Cowan University, has been awarded $490,500 through the highly competitive Australia Economic Accelerator Ignite Round 2 program.
St George Mining (ASX:SGQ) has extended its strategic alliance with US-based REalloys, originally announced in September 2025.